Beginning in 2008, a vaccine against HPV 16 and 18 was offered to boys and girls aged 12‒13 years in the USA and Europe, followed by a catch-up programme in girls aged 14‒18 years. By 2021, a UK study found a reduction in cervical cancer ranging from 34 per cent in those vaccinated at 16‒
